Close
Digital Health & Ai Innovation summit 2026
APE 2026

Omega Healthcare among top 2 in ‘Market Impact’ and ‘Vision & Capability’, in the global Healthcare BPO Service Provider Market Assessment

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Novartis Plans its Fourth US Radioligand...

Novartis, which is a world-leading innovative medicines company, has...

Tempus-NYU Langone Collaboration Advances Precision Oncology

Tempus and NYU Langone Health have signed a multi-year...

Boston Scientific Valencia Acquisition Expands Portfolio

Boston Scientific has entered into an agreement to acquire...

Outperforming many well-entrenched businesses with its wide-ranging capabilities and diversified business footprint, Omega Healthcare breaks new ground in this critical study.

The detailed analysis of the healthcare BPO service provider landscape covered the prominent companies that together account for a major portion of global market share, evaluating them on their revenue share, growth potential, business processes, and financials & network management among other parameters.

Speaking on the occasion Gopi Natarajan, Co-founder and CEO, Omega Healthcare says, “It is a matter of pride for us at Omega Healthcare to be recognized as a leader in the healthcare BPO service provider space.

While endorsement from Everest – a reputed, neutral body – reiterates our expertise across the healthcare services spectrum, it also underlines the fact our strategic growth has resulted from relentless efforts to deliver more value to our clients, consistently.

With digitization being the way forward, we are channelizing our efforts into providing innovative tech-enabled services and analytical solutions to our clients; the future looks very exciting.”

Latest stories

Related stories

Novartis Plans its Fourth US Radioligand Therapy Facility

Novartis, which is a world-leading innovative medicines company, has...

Tempus-NYU Langone Collaboration Advances Precision Oncology

Tempus and NYU Langone Health have signed a multi-year...

Boston Scientific Valencia Acquisition Expands Portfolio

Boston Scientific has entered into an agreement to acquire...

Haemonetics Vivasure Acquisition Reaches Valuation of €185M

Haemonetics has agreed to acquire Vivasure Medical for up...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »